Form 4: Camp4 Therapeutics Director Douglas E. Williams Reports Stock Option Grant

Director Douglas E. Williams reports receiving a stock option grant from Camp4 Therapeutics.

Summary

• On March 17, 2025, Douglas E. Williams, a director of Camp4 Therapeutics Corp, was granted a stock option to purchase 17,787 shares of common stock.
• The exercise price of the option is $5.37 per share.
• The options vest in equal monthly installments over three years, starting from the grant date.
• The option expires on March 16, 2035.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing related to stock option grants, which is neutral in sentiment.

Positives

• The grant of stock options aligns the director's interests with those of the shareholders, incentivizing him to work towards the company's success.

Industry Context

Stock option grants are a common form of compensation for directors and executives in publicly traded companies, particularly in the biotechnology industry, to incentivize performance and align interests with shareholders.

Stakeholder Impact

• The stock option grant could potentially dilute existing shareholders' equity if the options are exercised.

Key Dates

Keywords

stock option, director, Camp4 Therapeutics, beneficial ownership, Form 4, securities